Oral Drug Delivery Market to Grow at 7.74% CAGR through 2029
Rising
prevalence of chronic diseases and increasing healthcare expenditure is
expected to drive the Global Oral Drug Delivery Market growth in the forecast
period, 2025-2029.
According to
TechSci Research report, “Oral Drug Delivery Market – Global Industry Size,
Share, Trends, Competition Forecast & Opportunities, 2019-2029F”, the
Global Oral Drug Delivery Market stood at USD
120.44 Billion in 2023 and is anticipated to project steady growth in
the forecast period with a CAGR of 7.74%
through 2029. Growing
prevalence of chronic diseases worldwide, advancements in pharmaceutical
formulations and drug delivery technologies are pushing innovation in oral drug
delivery.
Browse over XX
market data Figures spread through XX Pages and an in-depth TOC on
"Global Oral Drug Delivery Market”
The global oral
drug delivery market is characterized by a dynamic and multifaceted landscape
shaped by a myriad of interconnected factors. One of the primary drivers of
this market expansion is the escalating prevalence of chronic diseases
worldwide. With conditions such as diabetes, cardiovascular diseases, and
respiratory ailments on the rise, there is a growing need for effective
medication delivery methods to manage these conditions. Furthermore, the
demographic shift towards an increasingly aging population amplifies this
demand, as older individuals typically require long-term medication regimens
for multiple chronic conditions.
Concurrently,
there is a surging consumer preference for convenient medication administration
methods, fueling the demand for oral drug delivery systems. Patients seek ease
of use, improved compliance, and enhanced therapeutic outcomes, prompting
pharmaceutical companies to invest heavily in research and development to
innovate new formulations and technologies. These advancements range from novel
drug formulations to sophisticated delivery mechanisms, all aimed at optimizing
drug efficacy and patient experience.
In addition to
technological innovation, regulatory initiatives play a pivotal role in shaping
the market landscape. Regulatory bodies worldwide are implementing measures to
streamline drug approval processes, ensuring both the efficacy and safety of
oral drug delivery products. These efforts foster a conducive environment for
market growth, instilling confidence among stakeholders and facilitating timely
market entry of new products. Moreover, emerging markets are emerging as
significant drivers of market expansion. Rapid urbanization, coupled with
increasing healthcare expenditure, presents lucrative opportunities for market
players to expand their footprint and tap into previously untapped consumer
segments. However, despite these growth opportunities, the market is not
without its challenges. Patent expirations, generic competition, and stringent
regulatory requirements pose significant obstacles to market growth, requiring
companies to navigate carefully to maintain their competitive edge.
The Global Oral
Drug Delivery Market is segmented into formulation, type, therapy area, end
user, regional distribution, and company
Based on therapy
area, Oncology emerges as the dominant player in the Global Oral Drug Delivery
Market. Several factors contribute to its prominence in this market segment. There
has been a significant rise in the incidence and prevalence of various types of
cancer globally. As a result, there is a growing demand for effective and
convenient oral drug delivery systems for the treatment of oncological
conditions.
Advancements in oncology research and drug
development have led to the introduction of a wide range of oral cancer
therapies, including targeted therapies, immunotherapies, and chemotherapy
agents. These oral medications cater to the diverse needs of cancer patients,
offering personalized treatment options and improved therapeutic outcomes.
Furthermore, pharmaceutical companies are investing heavily in the development
of innovative oral drug delivery technologies specifically tailored for
oncology, further driving market growth in this segment. Overall, the Oncology
sector stands out as the dominant force in the Global Oral Drug Delivery
Market, driven by the increasing prevalence of cancer and ongoing advancements
in cancer treatment modalities.
Based on region,
North America dominates the Global Oral Drug Delivery Market for several key
reasons. The region boasts a robust pharmaceutical industry with significant
investments in research and development (R&D). This investment fuels
continuous innovation in oral drug delivery technologies, driving the
development of new formulations and delivery systems. North America benefits
from advanced healthcare infrastructure and a well-established regulatory framework.
This facilitates the development, approval, and commercialization of oral drug
delivery products, ensuring efficient market entry and widespread availability.
Moreover, the
prevalence of chronic diseases, such as diabetes, cardiovascular diseases, and
respiratory conditions, is high in North America. As oral drug delivery is
often the preferred method of treatment for these conditions due to its
convenience and patient compliance, the demand for oral medications remains
consistently strong.
Major companies
operating in Global Oral Drug Delivery Market are:
- Novartis AG
- Biocon Ltd.
- NovoNordisk A/S
- F.Hoffmann-La
Roche Ltd.
- Bayer AG
- Emishphere
Technologies Inc.
- Enteris
Biopharma Inc.
- Merrion
Pharmaceuticals Plc.
- Amgen Inc.
- Pfizer Inc.
Download Free Sample Report
Customers can
also request for 10% free customization on this report
“The future of
the Oral Drug Delivery Market appears poised for unprecedented growth and
innovation. Advancements in drug delivery technologies, coupled with evolving
healthcare needs and shifting consumer preferences, are set to redefine the
landscape of oral medication administration. One of the most notable trends
shaping the future of the Oral Drug Delivery Market is the rise of personalized
medicine. With the advent of precision medicine and pharmacogenomics, there is
a growing recognition of the importance of tailoring drug therapies to
individual patient characteristics. This trend is driving the development of
personalized oral drug delivery systems capable of delivering precise dosages
and formulations tailored to meet the unique needs of each patient.,” said Mr.
Karan Chechi, Research Director with TechSci Research, a research-based
management consulting firm.
“Oral
Drug Delivery Market - Global Industry Size, Share, Trends, Opportunity, and
Forecast, Segmented By Formulation (Tablets, Capsules, Drops, Liquid or Syrup),
By Type (Controlled Release, Orodispersible Tablets, Others), By Therapy Area
(Oncology, Musculoskeletal, Immunology, Gastrointestinal, Respiratory,
Cardiovascular, Others), By End User (Hospitals, Ambulatory Surgical Centres,
Diagnostic Centres, Clinics, Others), By Region and Competition, 2019-2029F”,
has evaluated the future growth potential of Global Oral Drug Delivery Market
and provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Oral Drug Delivery Market.
Contact
TechSci
Research LLC
420
Lexington Avenue, Suite 300,
New York,
United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com